Physician profile
Benjamin Silverberg
NPI 1851956262
$643.82
in general payments reported to CMS, 2019-2025
15 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $91.50 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552 · Education: $91.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.32 |
| Education | $91.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $169.53 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Veloxis Pharmaceuticals, INC. | $91.50 | 2024 | |
| Fresenius USA Marketing, INC. | $63.80 | 2025 | Velphoro |
| Mallinckrodt Hospital Products INC. | $52.65 | 2025 | Terlivaz, Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $41.80 | 2025 | |
| Amgen INC. | $30.92 | 2025 | Tavneos |
| Otsuka America Pharmaceutical, INC. | $27.17 | 2025 | Jynarque |
| Lilly USA, LLC | $24.28 | 2025 | Jardiance |
| Nxstage Medical, INC. | $24.09 | 2025 | Nxstage System One |
| Calliditas Therapeutics US INC. | $22.87 | 2025 | Tarpeyo |
| Vifor Pharma, INC. | $20.34 | 2025 | Veltassa |
| Opko Pharmaceuticals, LLC | $19.99 | 2025 | Rayaldee |
| Alexion Pharmaceuticals, INC. | $19.97 | 2025 | Ultomiris |
| Novo Nordisk INC | $19.34 | 2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.57 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Silverberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.